Aktieanalys

Biovica Commercial Update: A US and European launch within 12 months - Redeye

{newsItem.title}

Redeye Publicerad: 19 Aug 2022 09:02

Biovica recently hosted a post-FDA approval commercial update for DiviTum on the 18th of August. The company is on track for a US launch in early 2023.

Länk till analysen i sin helhet: https://www.redeye.se/research/852242/biovica-commercial-update-a-us-and-european-launch-within-12-months?utm_source=finwire&utm_medium=RSS

Nyheter om Biovica

Läses av andra just nu

Om aktien Biovica

Senaste nytt